News

Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society (LLS). The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.

Parents and doctors often have to consider the mother's health as well as the potential risk regarding how medication could affect their baby. Researchers have developed a process to make a 3D tissue model that could mimic early stage human heart development, which could aid drug safety testing and help determine a drug's effects on fetal development.

Fusing together healthy cells with those affected by Duchenne Muscular Dystrophy could improve muscle function.

A small, daily dose of Viagra significantly reduces colorectal cancer risk in an animal model that is genetically predetermined to have the third leading cause of cancer death, scientists report.

Researchers have discovered a new method to resolve the problem of forgetting a person's name, by tapping into a natural memory change during aging.

To assist with wound healing, mesenchymal stem cells from the gum tissue secrete extracellular vesicles that contain the anti-inflammatory signaling molecule IL-1RA.

Dr. Patrick E. Williams has served on the National Scientific Review Board for the Human Genome Project, provided technical leadership to the Armed Forces DNA Technology Development Program and served on numerous NIH Study Sections on technology development.

Aeos Labs is the third laboratory in the state to earn certification for testing of medical cannabis. Steep Hill Hawai‘i on O‘ahu received certification last year in July and Pharmlabs Hawai‘i, LLC on Maui was certified last year in October.

The VCT-1 is the first in a line of next-generation extraction technology, creating the closest thing to vaping or smoking, only cleaner, at lower cost, superior quality, and with precision dosing.

Drug-resistant bacteria are often seen as an inevitability but new research shows how science is fighting back.